Related Experiment Video
Updated: Nov 29, 2025

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Diabetes impairs periosteal progenitor regenerative potential
Laura Doherty1, Matthew Wan1, Ivo Kalajzic2
1Department of Orthopaedic Surgery, UConn Musculoskeletal Institute, UConn Health, Farmington, CT, USA.
Diabetes impairs fracture healing by affecting the periosteum, a key tissue for bone repair. Diabetic mice showed reduced periosteal progenitor cells and impaired bone formation, leading to delayed healing.
Area of Science:
- Orthopedics
- Endocrinology
- Regenerative Medicine
Background:
- Diabetes mellitus significantly increases fracture risk and impairs bone healing.
- The periosteum is crucial for fracture repair, containing progenitors for bone regeneration.
- Previous research focused on bone marrow cells, neglecting the periosteum's role in diabetic bone repair.
Purpose of the Study:
- To investigate the impact of type I diabetes on periosteal progenitor cells.
- To evaluate the periosteum's contribution to fracture healing in a diabetic environment.
Main Methods:
- Utilized a murine model of type I diabetes.
- Assessed periosteal cell differentiation capacity and proliferation in vitro.
- Analyzed fracture callus mineralization and osteoblast activity in vivo.
Main Results:
- Periosteal cells from diabetic mice exhibited deficient osteogenic differentiation.
- Diabetic mice showed reduced periosteal mesenchymal progenitor populations and proliferation post-injury.
- Fracture callus mineralization and mature osteoblast activity were impaired in diabetic mice.
Conclusions:
- Diabetes negatively affects periosteal progenitor cell function and availability.
- Impaired periosteal contribution to bone regeneration directly contributes to delayed fracture healing in diabetes.
- Targeting periosteal cells may offer new therapeutic strategies for diabetic bone repair.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Tissue Renewal without Stem Cells
However, failure of such a system...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

